0 Share
InterviewODwire.org RadioTechnology

Contact Lens Technology to Meet Patient Needs in the Digital Age

ODwire.org Radio #56:
In this episode, Adam & Paul speak with Dr. Christopher Lievens, all about how the needs of contact lens patients are evolving as more and more of us spend our days glued to digital devices!

We cover:

  • The challenges heavy digital device users face with contact lenses, including dry eye
  • Strategies to help these patients be successful with their contact lens wear
  • The latest contact lens technologies, including DAILIES® AquaComfort Plus® lenses

If you’ve got any questions for Dr. Lievens, this is the thread for them!
—
Dr. Lievens received financial compensation from Alcon for his participation in this podcast.
See product instructions for complete wear, care and safety information.
© 2016 Novartis 12/16 US-DAP-16-E-2100j

[#R056]

Continue Reading
0 Share
ODwire.org RadioPractice ManagementTechnology

Patient and Practice Success: Offering One-of-a-Kind Daily Disposable Contact Lenses [#R055]

In this episode, Adam & Paul speak with Dr. Steven Bennett about the DAILIES TOTAL1® contact lens, and how he’s integrated it into his practice.

We cover:

  • The latest technological advances in daily disposable lenses.
  • How he has managed to fit the vast majority of his contact lens patients in daily disposables, and the DT1specifically.
  • How to select the right patients for this lens.

If you’ve got any questions for Dr. Bennett, this is the thread for them!

Continue Reading
0 Share
ODwire.org Radio

The Evolution of Flexible Wear, Current “Best Practices” & Materials (AONDA!) [#R054]

In this episode, Adam & Paul speak with Dr. Jessica Crooker of Scituate Harbor Vision in Scituate, MA.

We discuss how the notion of flexible wear has evolved over the past 50 years (yes, the concept has been around that long!) and the current ‘state of the art’ in flexible wear products.

We turn our attention to AIR OPTIX® NIGHT & DAY® AQUA lenses, how they fit into this pattern of material and design evolution, and discuss the patients most likely to succeed with this modality.

If you have any questions for Dr. Crooker (clinical, practice management, or otherwise) fire away in this thread!

— Adam

—
Dr. Crooker was compensated by Alcon for her participation in this interview.

©2016 Novartis 11/16 US-AND-16-E-4240

Continue Reading